Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications
Associations of neighborhood deprivation with breast cancer tumor genomics, targeted treatment use, and survival.
Journal: Breast cancer research and treatment
Published: February 15, 2026
Spatial Mapping of the Precancer-to-Cancer Transition in Breast and Prostate.
Journal: Cancer discovery
Published: January 11, 2026
Impact of Financial Incentives on Electronic Health Record-Driven Recruitment of Underrepresented Communities in Research: Randomized Controlled Trial.
Journal: Journal of medical Internet research
Published: October 18, 2025
Neoadjuvant Endocrine Treatment plus Mammaglobin-A DNA Vaccine Induces Antitumor Immune Responses in the Primary Tumor and Peripheral Blood of Patients with Breast Cancer: Insights from a Phase Ib Clinical Trial.
Journal: Cancer immunology research
Published: May 28, 2025
Racial Differences in ctDNA Profiles, Targeted Therapy Use, and Outcomes in Metastatic Breast Cancer.
Journal: JAMA network open
Published: February 26, 2025
Detection of Circulating Tumor DNA Using a Tissue-Free Epigenomic Assay Is a Highly Prognostic Biomarker in Early-Stage Triple-Negative Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 21, 2024
Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial.
Journal: Nature communications
Published: October 17, 2024
Impact of National Society Guidelines and National Comprehensive Cancer Network (NCCN) Guidelines on Genetic Testing Use Among Patients with Breast Cancer.
Journal: Annals of surgical oncology
Published: July 03, 2024
Radiologic imaging biomarkers in triple-negative breast cancer: a literature review about the role of artificial intelligence and the way forward.
Journal: BJR artificial intelligence
Published: June 27, 2024
Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages.
Journal: bioRxiv : the preprint server for biology
Published: November 14, 2023
Low RNA disruption during neoadjuvant chemotherapy predicts pathologic complete response absence in patients with breast cancer.
Journal: JNCI cancer spectrum
Published: August 24, 2023
Evaluation of markers of immunity in different metastatic immune microenvironments suggests more suppression within breast to liver metastases in breast cancer.
Journal: Breast cancer research and treatment
Published: August 05, 2023
Last Updated: 09/26/2026